Corbus Pharmaceuticals Holdings, Inc. Capital Expenditures
Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported Capital Expenditures of $12.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-06
- Corbus Pharmaceuticals Holdings, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $6.00K.
- Corbus Pharmaceuticals Holdings, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $6.00K.
- Corbus Pharmaceuticals Holdings, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-06-30 was $0.00.
- Corbus Pharmaceuticals Holdings, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-03-31 was $0.00.
- Corbus Pharmaceuticals Holdings, Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $7.00K.
- Corbus Pharmaceuticals Holdings, Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $0.00.
- Corbus Pharmaceuticals Holdings, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Corbus Pharmaceuticals Holdings, Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $13.45K, a 75.17% decline from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $12.00K 10-Q · filed 2026-08-06 | ||
| 2026-03-31 | $6.00K 10-Q · filed 2026-05-12 | |||
| 2025-12-31 | $7.00K 10-K · filed 2026-03-09 | |||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 | ||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-12 | |||
| 2024-12-31 | $0.00 10-K · filed 2026-03-09 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $0.00 derived: sum of 2 quarters · filed 2024-03-12 | $0.00 derived: sum of 3 quarters · filed 2024-03-12 | $0.00 10-K · filed 2024-03-12 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $0.00 derived: sum of 2 quarters · filed 2023-11-07 | $0.00 10-Q · filed 2023-11-07 | $0.00 derived: sum of 4 quarters · filed 2024-03-12 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $0.00 10-Q · filed 2023-08-08 | $0.00 derived: sum of 3 quarters · filed 2024-03-12 | $0.00 derived: sum of 4 quarters · filed 2024-03-12 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-09 | $0.00 derived: sum of 2 quarters · filed 2024-03-12 | $0.00 derived: sum of 3 quarters · filed 2024-03-12 | $0.00 derived: sum of 4 quarters · filed 2024-03-12 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $0.00 derived: sum of 2 quarters · filed 2024-03-12 | $0.00 derived: sum of 3 quarters · filed 2024-03-12 | $13.45K 10-K · filed 2024-03-12 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $0.00 derived: sum of 2 quarters · filed 2023-11-07 | $13.45K 10-Q · filed 2023-11-07 | $67.62K derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $13.45K 10-Q · filed 2023-08-08 | $67.62K derived: sum of 3 quarters · filed 2023-08-08 | |
| 2022-03-31 | $13.45K 10-Q · filed 2023-05-09 | $67.62K derived: sum of 2 quarters · filed 2023-05-09 | ||
| 2021-12-31 | $54.17K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | $54.17K 10-K · filed 2023-03-07 | ||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-08 | |||
| 2020-12-31 | -$52.09K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $4.71K derived: sum of 2 quarters · filed 2022-03-08 | $20.89K derived: sum of 3 quarters · filed 2022-03-08 | $484.49K 10-K · filed 2022-03-08 |
| 2020-09-30 | $56.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $72.97K derived: sum of 2 quarters · filed 2021-11-12 | $536.58K 10-Q · filed 2021-11-12 | $1.83M derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $16.17K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $479.78K 10-Q · filed 2021-08-12 | $1.77M derived: sum of 3 quarters · filed 2021-08-12 | $2.97M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $463.61K 10-Q · filed 2021-05-13 | $1.76M derived: sum of 2 quarters · filed 2021-05-13 | $2.95M derived: sum of 3 quarters · filed 2021-05-13 | $3.13M derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $2.49M derived: sum of 2 quarters · filed 2021-03-15 | $2.67M derived: sum of 3 quarters · filed 2021-03-15 | $2.74M 10-K · filed 2021-03-15 |
| 2019-09-30 | $1.19M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2020-11-09 | $1.38M derived: sum of 2 quarters · filed 2020-11-09 | $1.45M 10-Q · filed 2020-11-09 | $1.70M derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | $183.28K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2020-08-31 | $256.90K 10-Q/A · filed 2020-08-31 | $506.65K derived: sum of 3 quarters · filed 2020-08-31 | $612.45K derived: sum of 4 quarters · filed 2020-08-31 |
| 2019-03-31 | $73.61K 10-Q · filed 2020-05-11 | $323.37K derived: sum of 2 quarters · filed 2020-05-11 | $429.17K derived: sum of 3 quarters · filed 2020-05-11 | $1.10M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $249.75K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $355.55K derived: sum of 2 quarters · filed 2020-03-16 | $1.03M derived: sum of 3 quarters · filed 2020-03-16 | $2.30M 10-K · filed 2020-03-16 |
| 2018-09-30 | $105.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $780.95K derived: sum of 2 quarters · filed 2019-11-07 | $2.05M 10-Q · filed 2019-11-07 | $2.63M derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $675.15K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $1.94M 10-Q · filed 2019-08-08 | $2.53M derived: sum of 3 quarters · filed 2019-08-08 | $2.57M derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-03-31 | $1.27M 10-Q · filed 2019-05-09 | $1.85M derived: sum of 2 quarters · filed 2019-05-09 | $1.90M derived: sum of 3 quarters · filed 2019-05-09 | $1.94M derived: sum of 4 quarters · filed 2019-05-09 |
| 2017-12-31 | $580.18K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $625.61K derived: sum of 2 quarters · filed 2019-03-12 | $667.30K derived: sum of 3 quarters · filed 2019-03-12 | $707.43K 10-K · filed 2019-03-12 |
| 2017-09-30 | $45.43K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $87.11K derived: sum of 2 quarters · filed 2018-11-08 | $127.25K 10-Q · filed 2018-11-08 | $223.26K derived: sum of 4 quarters · filed 2018-11-08 |
| 2017-06-30 | $41.69K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $81.82K 10-Q · filed 2018-08-08 | $177.83K derived: sum of 3 quarters · filed 2018-08-08 | $247.70K derived: sum of 4 quarters · filed 2018-08-08 |
| 2017-03-31 | $40.13K 10-Q · filed 2018-05-10 | $136.15K derived: sum of 2 quarters · filed 2018-05-10 | $206.01K derived: sum of 3 quarters · filed 2018-05-10 | $327.84K derived: sum of 4 quarters · filed 2018-05-10 |
| 2016-12-31 | $96.02K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $165.88K derived: sum of 2 quarters · filed 2018-03-12 | $287.71K derived: sum of 3 quarters · filed 2018-03-12 | $353.03K 10-K · filed 2018-03-12 |
| 2016-09-30 | $69.86K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $191.69K derived: sum of 2 quarters · filed 2017-11-08 | $257.01K 10-Q · filed 2017-11-08 | $350.01K derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-06-30 | $121.83K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $187.15K 10-Q · filed 2017-08-09 | $280.15K derived: sum of 3 quarters · filed 2018-03-12 | $284.97K derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-03-31 | $65.32K 10-Q · filed 2017-05-09 | $158.32K derived: sum of 2 quarters · filed 2018-03-12 | $163.14K derived: sum of 3 quarters · filed 2018-03-12 | $177.63K derived: sum of 4 quarters · filed 2018-03-12 |
| 2015-12-31 | $93.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $97.81K derived: sum of 2 quarters · filed 2018-03-12 | $112.31K derived: sum of 3 quarters · filed 2018-03-12 | $114.04K 10-K · filed 2018-03-12 |
| 2015-09-30 | $4.81K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $19.31K derived: sum of 2 quarters · filed 2016-11-10 | $21.04K 10-Q · filed 2016-11-10 | $21.04K derived: sum of 4 quarters · filed 2016-11-10 |
| 2015-06-30 | $14.49K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12 | $16.22K 10-Q · filed 2016-08-12 | $16.22K derived: sum of 3 quarters · filed 2016-08-12 | $72.66K derived: sum of 4 quarters · filed 2016-08-12 |
| 2015-03-31 | $1.73K 10-Q · filed 2016-05-13 | $1.73K derived: sum of 2 quarters · filed 2016-05-13 | $58.17K derived: sum of 3 quarters · filed 2016-05-13 | |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28 | $56.44K derived: sum of 2 quarters · filed 2016-03-28 | $64.45K 10-K · filed 2016-03-28 | |
| 2014-09-30 | $56.44K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | $64.45K 10-Q · filed 2015-11-10 | ||
| 2014-06-30 | $8.01K 10-Q · filed 2015-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |